Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

GeneMe, a Poland-based universal molecular genetic tests platform spun out of Institute of Biotechnology and Molecular Medicine, has closed a €5.2m ($6.4m) seed round led by Robin Tombs, with participation from other angel investors, TechCrunch reported yesterday. The spinout’s offering includes three tests for covid-19. GeneMe’s technology can be assembled at the point of care…

The rest of this content is only accessible to University Venturing: News, Data and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.